Stock listing
NASDAQ:OPNT Opiant Pharmaceuticals Inc Stock
Follow Opiant Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:OPNT
$20.65 USD
Close on Mar 2, 2023 · No longer trades
- Lowest – highest close
- $3.35 – $50.50 USDSince Jan 5, 2015 · lowest Jan 15, 2015 · highest Sep 7, 2017
Delisted NASDAQ:OPNT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OPNT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Opiant Pharmaceuticals Inc on 6ix
- Calls
- 5 calls with a replay · 5 with a transcript · latest Aug 11, 2022
- Decks
- 5 decks · latest Feb 16, 2023
Events
| Call | When | Status |
|---|---|---|
| Opiant Pharmaceuticals (OPNT) Q2 2022 Earnings Call | Thu, Aug 11, 2022 · 4:30 PM ET | Replay |
| Opiant Pharmaceuticals (OPNT) Q1 2022 Earnings Call | Tue, May 10, 2022 · 4:30 PM ET | Replay |
| Opiant Pharmaceuticals (OPNT) Q4 2021 Earnings Call | Tue, Mar 15, 2022 · 4:30 PM ET | Replay |
| Opiant Pharmaceuticals (OPNT) Q3 2021 Earnings Call | Thu, Nov 11, 2021 · 4:30 PM ET | Replay |
| Opiant Pharmaceuticals (OPNT) Q1 2021 Earnings Call | Tue, May 11, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2022 Earnings Presentation | Earnings | 19 slides | Feb 16, 2023 |
| Merger or Acquisition (November 2022) | Merger or acquisition | 17 slides | Nov 15, 2022 |
| Investor Presentation (September 2017) | Investor deck | 39 slides | Sep 12, 2017 |
| Investor Presentation (April 2017) | Investor deck | 34 slides | Apr 19, 2017 |
| Investor Presentation (September 2016) | Investor deck | 27 slides | Sep 13, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard J Daly Other companies: Aquestive Therapeutics, Inc. (Director · Since at least Nov 10, 2026); Catalyst Pharmaceuticals, Inc. (President and CEO, Director · Since at least Dec 30, 2015); Palisade Bio, Inc. (Chief Executive Officer, Director · Feb 15, 2016 – Nov 7, 2017 · Past); Synergy Pharmaceuticals Inc (Director · Jun 30, 2015 – Jun 28, 2017 · Past) | Director · Jun 12, 2018 – Mar 2, 2023 · Past |
| Craig Collard Other companies: Heron Therapeutics, Inc. (Chief Executive Officer · Since at least Feb 22, 2023); TerrAscend Corp. (Director · Since at least Jan 6, 2022); Sierra Oncology Inc (Director · May 26, 2020 – Jul 1, 2022 · Past) | Director · Jun 12, 2019 – Mar 2, 2023 · Past |
| Kevin Pollack Other companies: Taronis Fuels Inc (Director · Mar 30, 2020 – Jan 7, 2021 · Past); Taronis Technologies Inc (Director · Apr 1, 2019 – Nov 21, 2019 · Past); Pressure BioSciences, Inc. (Director · Jul 3, 2012 – Mar 27, 2024 · Past) | See Remarks, Director · Apr 17, 2012 – Jan 13, 2017 · Past |
| Aziz Mottiwala Other companies: RxSight, Inc. (President and Chief Executive Officer · Since at least Jul 20, 2026); Tarsus Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Oct 15, 2020) | Chief Commercial Officer · Sep 20, 2019 – Sep 20, 2019 · Past |
| Masuoka K Lorianne Other companies: DiaMedica Therapeutics Inc. (Chief Medical Officer · Jan 22, 2024 – Jan 22, 2024 · Past); Marinus Pharmaceuticals Inc (Chief Medical Officer · Dec 6, 2017 – Aug 21, 2019 · Past) | Director · Mar 18, 2021 – Mar 2, 2023 · Past |
| Ann L MacDougall Other companies: Progenics Pharmaceuticals Inc (Director · Dec 13, 2019 – Jun 19, 2020 · Past) | Director · Jun 12, 2019 – Mar 2, 2023 · Past |
| David O’Toole Other companies: Avita Medical, Inc. (Chief Financial Officer · Since at least Jun 15, 2023) | Chief Financial Officer · Sep 12, 2017 – Mar 2, 2023 · Past |
| Roger Crystal Other companies: Definium Therapeutics, Inc. (Compensation · Since at least Aug 11, 2022) | Chief Executive Officer, Director · Dec 10, 2014 – Mar 2, 2023 · Past |
| Geoffrey Wolf | Director · Dec 10, 2014 – Dec 10, 2014 · Past |
| Mark Jason Heath Ellison | Chief Development Officer · Jan 26, 2021 – Mar 2, 2023 · Past |
All 14 people
| Person | Seat |
|---|---|
| Matthew R Ruth | Chief Commercial Officer · Jul 19, 2021 – Mar 2, 2023 · Past |
| Michael Sinclair | Director · May 18, 2012 – Mar 2, 2023 · Past |
| Phil Skolnick | Chief Scientific Officer · Apr 1, 2019 – Mar 2, 2023 · Past |
| Thomas T Thomas | Director · Jun 12, 2019 – Mar 2, 2023 · Past |
Log in to ask 6ix AI your own questions about Opiant Pharmaceuticals Inc.